|
YALE COMPREHENSIVE CANCER CENTER
|
2P30CA016359-29
|
$1,871,000
|
$56,130
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
WUMC-Cancer and Leukemia Group B
|
5U10CA077440-10
|
$334,381
|
$6,688
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Workshops on Viral Pathogenesis and Oncogenesis
|
5R13CA095919-06
|
$13,482
|
$3,371
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Washington University Molecular Imaging Center
|
2P50CA094056-07
|
$2,000,000
|
$660,000
|
PIWNICA-WORMS, David
|
WASHINGTON UNIVERSITY
|
|
Washington University Molecular Imaging Center
|
5P50CA094056-06
|
$363,851
|
$120,071
|
PIWNICA-WORMS, David
|
WASHINGTON UNIVERSITY
|
|
Visualizing Tumors and Mechanisms of Therapy in Vivo
|
5R01CA080006-08
|
$234,613
|
$117,307
|
NEGRIN, ROBERT
|
STANFORD UNIVERSITY
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-24S1
|
$80,000
|
$1,600
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-24
|
$391,000
|
$7,820
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Viral and cellular gene regulation during lytic KSHV replication
|
5R01CA119905-02
|
$223,783
|
$111,892
|
Swaminathan, Sankar
|
UNIVERSITY OF FLORIDA
|
|
VCU Minority-Based CCOP
|
3U10CA052784-17S1
|
$100,000
|
$2,000
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based CCOP
|
5U10CA052784-17
|
$527,332
|
$10,547
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
2P30CA014520-34
|
$4,748,000
|
$237,400
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-34S1
|
$56,723
|
$2,836
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-34S2
|
$239,556
|
$11,978
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UT M.D. Anderson Cancer Center
|
2U10CA045809-19
|
$1,362,206
|
$27,244
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
|
5R01CA102646-03
|
$308,531
|
$101,815
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-32
|
$6,578,401
|
$328,920
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-23
|
$1,740,827
|
$34,817
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
UNRESOLVED PUBLIC HEALTH ISSUES RELATED TO HT AND CANCER
|
5P01CA017054-29
|
$2,094,891
|
$712,263
|
HENDERSON, BRIAN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Unraveling germinal center B cell lymphoma development
|
5R01CA102739-04
|
$271,155
|
$271,155
|
TSIAGBE, VINCENT
|
UNIV OF MED/DENT OF NJ-NJ DENTAL SCHOOL
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-23S1
|
$75,930
|
$15,945
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-23S2
|
$172,091
|
$36,139
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-23S3
|
$175,726
|
$36,902
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-23
|
$1,493,701
|
$313,677
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Rochester Cancer Center CCOP Research Base
|
3U10CA037420-23S1
|
$146,724
|
$14,672
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-23
|
$1,131,018
|
$113,102
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-20S2
|
$59,280
|
$593
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-20S3
|
$114,000
|
$1,140
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-20
|
$5,929,129
|
$59,291
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center CCOP*
|
3U10CA074648-06S1
|
$14,723
|
$147
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Iowa CALGB Institutional Grant
|
5U10CA047642-20
|
$119,291
|
$2,386
|
VAENA, DANIEL
|
UNIVERSITY OF IOWA
|
|
University of Colorado Southwest Oncology Group
|
2U10CA042777-20
|
$82,102
|
$8,210
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
University of Colorado Southwest Oncology Group
|
3U10CA042777-20S1
|
$356,613
|
$35,661
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
Uncoupling of Jak/STAT in HTLV-1 associated leukemia
|
1R01CA115398-01A2
|
$223,440
|
$111,720
|
NICOT, CHRISTOPHE
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
UMB/DFHCC Comprehensive Cancer Partnership Program
|
5U56CA118635-03
|
$425,744
|
$85,149
|
Colon-Carmona, Adan
|
UNIVERSITY OF MASSACHUSETTS BOSTON
|
|
UCB-DERIVED CD19-SPECIFIC T CELLS FOR UNIVERSAL TREATMENT OF B-CELL MALIGNANCY
|
1R21CA116127-01A1
|
$202,499
|
$101,250
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
U10 Ful Member Application Affiliated with SWOG
|
5U10CA105409-04
|
$229,230
|
$22,923
|
LIPPMAN, SCOTT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Tumor Suppressor Protein, p53
|
Z01 BC 005599
|
$543,233
|
|
Appella, Ettore
|
CCR (NCI)
|
|
Tumor Banking for the Southwest Oncology Group
|
5U24CA114748-03
|
$999,441
|
$99,944
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Treatment of Infections in Immunocompromised Children with Cancer, Hematopoietic
|
Z01 SC 006830
|
$1,901,448
|
|
Walsh, Thomas
|
CCR (NCI)
|
|
Transformation of Cells by the REL Oncogene
|
5R01CA047763-20
|
$275,637
|
$275,637
|
GILMORE, THOMAS
|
BOSTON UNIVERSITY
|
|
Transformation by Reticuloendotheliosis Virus
|
2R01CA033192-20A2
|
$302,736
|
$302,736
|
BOSE, HENRY
|
UNIVERSITY OF TEXAS AUSTIN
|
|
Transcriptional silencing by the Bcl-6 oncoprotein
|
5R01CA104348-04
|
$259,688
|
$259,688
|
MELNICK, ARI
|
YESHIVA UNIVERSITY
|
|
TRANSCRIPTION FACTOR TARGET MAPPING IN MAMMALIAN GENOME
|
5R33CA105829-04
|
$314,826
|
$220,378
|
REN, BING
|
LUDWIG INSTITUTE FOR CANCER RESEARCH
|
|
Training Patients and Partners for HSCT: A Novel Coping Skills Intervention
|
1R03CA130725-01
|
$84,500
|
$42,250
|
Lawsin, Catalina
|
BERNARD M. BARUCH COLLEGE
|
|
TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035415-24
|
$791,551
|
$7,916
|
SCHAEFER, PAUL
|
TOLEDO COMMUNITY HOSPITAL ONCOLOGY PROG
|
|
Tissue Microarray Design and Development for Novel Gene and Gene Product Screenin
|
Z01 SC 010364
|
$515,375
|
|
Kleiner, David
|
CCR (NCI)
|
|
Thioredoxin Inhibition of Apoptosis and Cancer Treatment
|
5R01CA077204-09
|
$269,170
|
$33,646
|
POWIS, GARTH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
|
5P01CA044991-20
|
$1,865,350
|
$932,675
|
Press, Oliver
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Therapeutics Studies of Primary CNS Malignancies
|
5U01CA062407-13
|
$161,227
|
$1,612
|
WEN, PATRICK
|
DANA-FARBER CANCER INSTITUTE
|
Total relevant funding to Non Hodgkins lymphoma for this search: $112,959,162
|